Fortress Biotech (FRA:CNB1) EBIT per Share : €-14.45 (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Fortress Biotech EBIT per Share?

Fortress Biotech's EBIT per Share for the three months ended in Mar. 2024 was €-3.81. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-14.45.

During the past 3 years, the average EBIT per Share Growth Rate was 3.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 9.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was -6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Fortress Biotech's EBIT per Share or its related term are showing as below:

FRA:CNB1' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55.9 Med: -0.9 Max: 50.1
Current: 3.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Fortress Biotech was 50.10% per year. The lowest was -55.90% per year. And the median was -0.90% per year.

FRA:CNB1's 3-Year EBIT Growth Rate is ranked better than
50.46% of 1304 companies
in the Biotechnology industry
Industry Median: 3.6 vs FRA:CNB1: 3.70

Fortress Biotech's EBIT for the three months ended in Mar. 2024 was €-34.07 Mil.

Fortress Biotech EBIT per Share Historical Data

The historical data trend for Fortress Biotech's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech EBIT per Share Chart

Fortress Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-22.98

-15.95

-24.85

-32.35

-17.64

Fortress Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-7.13	-6.77	-1.09	-2.78	-3.81

Fortress Biotech EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Fortress Biotech's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-129.955	/	7.36628
=	-17.64

Fortress Biotech's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-34.068	/	8.93759
=	-3.81

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.45

Fortress Biotech (FRA:CNB1) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Fortress Biotech EBIT per Share Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortress Biotech (FRA:CNB1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (FRA:CNB1) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

FBIOP.PFD:USA FBIO:USA CNB0.PFD:Germany

Address

1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website

https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Fortress Biotech (FRA:CNB1) Headlines

No Headlines